About Timothy Bates
Dr. Bates has held academic and research posts at the University of Sheffield, the University of Southampton, The Royal College of Surgeons of England, University College London the University of Nottingham and research fellowships in Sweden, the USA and Italy. He has over 30 years experience in biomedical research with ongoing research projects in: mitochondrial metabolism, mitochondrial pharmacology, mitochondrial toxicity, cancer pharmacology and bacterial meningitis. Dr. Bates provides consultancy in the areas of mitochondrial pharmacology, mitochondrial biochemistry, mitochondrial toxicology and mitochondrial metabolism, both to international pharmaceutical companies and other major industrial clients/collaborators as well as to other research partners in the UK and abroad. Dr. Bates is an active member of the Biochemical Society, the British Pharmacological Society and the British Neuroscience Association and has spoken at many international scientific conferences in the UK, USA, Italy, France, Germany, Holland, and China. Dr. Bates is a regular grant reviewer for many U.K., USA and European research charities/organisations including the Medical Research Council, the Biotechnology and Biological Sciences Research Council, the Wellcome Trust, the European Union, the Italian Department of Science and Technology, The Portuguese Ministry of Education and Science, The Alzheimer’s Association (USA), The Parkinson’s Disease Society, AGE UK and The Special Trustees Fund of St. Thomas’ Hospital.
Module Leader in Pharmacology and Toxicology
Cancer, Pharmacology, Toxicology, Metabolism and Cellular Pathology
B.Sc. in Physiology (University of Sheffield, 1982)
Ph.D. in Metabolic Biochemistry and NMR spectroscopy (Royal College of Surgeons of England, 1989),
Royal Microscopical Society
Higher Education Academy
The Biochemical Society
The British Neuroscience Association
The British Pharmacological Society
External Activities and Consultancy
Dr. Bates is the Founder and Chief Scientific Officer of Drugs With A Difference Limited, a company he founded in 2013 based at BioCity Nottingham, Europe’s largest Bio-Incubator. Dr. Bates founded the company specifically to rapidly re-purpose existing drugs (not previously used in cancer) and develop Intellectual Property (IP) in the form of patents which will be licensed to international pharmaceutical companies, and bring them rapidly to the clinic for use in the treatment of several different cancer types, such as lung, breast, colon, prostate, brain, stomach and the nasopharynx. Dr. Bates is also a member of the external assessor panel for the NHS Evidence section of the National Institute of Health and Clinical Excellence (NICE), where his specialist areas of interest are: Drugs and Devices, Research, Interventional Procedures and Clinical (1).
Dr. Bates is also a scientific board member of the Purple Society, a major USA children’s cancer research foundation (2)